Pathogen | Treatment |
---|---|
Methicillin-resistant Staphylococcus aureus (MRSA) | See Table 2 |
Pseudomonas aeruginosa | Double coverage recommended. See Table 2 |
Acinetobacter species | Carbapenem |
 | e. g., imipenem + cilastin; 1 g every 8 hours; |
 | meropenem 1 g every 8 hours |
 | OR |
 | Beta-Lactam/beta-lactamase inhibitor |
 | e. g., ampicillin + sulbactam: 3 g every 8 |
 | hours |
 | OR |
 | Tigecycline: 100 mg loading dose, then 50 mg every 12 hours |
Extended-spectrum beta-lactamase (ESBL) positive enterobacteriaceae | Carbepenem |
 | e. g., imipenem + cilastin: 1 g every 8 hours; |
 | meropenem: 1 g every 8 hours |
Fungi | Fluconazole: 800 mg every 12 hours; |
 | caspofungin: 70 mg loading dose, then 50 mg daily; |
 | voriconazole (for aspergillus species): 4 mg/kg every 12 hours |
Legionella | Macrolides (e. g., azithromycin) |
 | OR |
 | Fluoroquinolones (e. g., levofloxacin) |